PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 10, 2025Diabetes Metabolic Syndrome and ObesityOpen Access

Effects of GLP-1RA Treatment on Long-Term Post-PCI Prognosis in T2DM Patients: A Propensity Score Matching Study

View Full Paper
Ask AI
Bookmark
Share

Authors

BFBinbin FangFLFen LiuJLJun‐Yi Luo

Discussion

Loading...

Member takes

Overview

Propensity score matching reveals GLP-1RA treatment improves cardiovascular outcomes in T2DM patients post-PCI.

Key Points

  • GLP-1RA treatment significantly lowers the risk of major adverse cardiovascular events (MACE) in T2DM patients after PCI.
  • Patients treated with GLP-1RA had lower total cholesterol, LDL-C, and HbA1c levels over 24 months compared to the control group.
  • Survival analysis shows a greater event-free survival rate in the GLP-1RA group, supporting earlier intervention benefits.
  • Univariate and multivariate analyses identified GLP-1RA use as an independent factor reducing MACE risk in T2DM patients.

Cite This Study

Fang et al. (2025) studied this question.

synapsesocial.com/papers/68c1d03e54b1d3bfb60f70b2https://doi.org/10.2147/dmso.s535325
View Full Paper
Ask AI
Bookmark
Share